Skip to main content

Month: July 2022

GameOn Completes US$550,000 Loan

VANCOUVER, British Columbia, July 12, 2022 (GLOBE NEWSWIRE) — GameOn Entertainment Technologies Inc. (“GameOn” or the “Company”) (CSE: GET) (OTCQB: GMETF), a leading game technology company partnered with the world’s biggest IPs to launch, operate, and monetize web3 prediction and fantasy games, announces that, further to its press release dated July 4, 2022, it has entered into a loan agreement with Proje Ventures Inc. (“Proje”) whereby the Company has borrowed an aggregate of US$550,000 from Proje (the “Loan”). The Company intends to use the proceeds from the Loan for general working capital purposes. GameOn reported $207,151 in revenue in Q1, 2022, up from $2,791 in Q1, 2021. Management believes that the Company is on track to reach $1m in revenue in 2022, not including income from revenue share arrangements, and is on track...

Continue reading

Societal CDMO Announces Signing of Amendment to License and Supply Agreement With Lannett for Marketing of Verapamil PM and Verelan SR Products

Societal to Receive Greater Portion of Profit Sharing from Verapamil PM Product Sales Societal Awarded Potential New GMP Manufacturing Agreements for Multiple Additional Lannett Products SAN DIEGO and GAINESVILLE, Ga., July 12, 2022 (GLOBE NEWSWIRE) — Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced that it has signed an amendment to its license and supply agreement with Lannett Company (“Lannett”) for the marketing of Verapamil PM and Verelan SR products. Under terms of the amendment, Societal will now receive improved overall economics, including a 10% increase in the profit share component of revenue from Verapamil PM product...

Continue reading

XPO Logistics Unveils RXO as Company Name for Planned Spin-Off

GREENWICH, Conn. , July 12, 2022 (GLOBE NEWSWIRE) — XPO Logistics, Inc. (NYSE: XPO), a leading provider of freight transportation services, today announced that a new company identity has been created in connection with the planned spin-off of its tech-enabled brokerage platform. The spin-off is named RXO to reflect the company’s commitment to provide reliability multiplied by outperformance. RXO will go to market with the tagline “Massive capacity. Cutting-edge technology.” XPO unveiled the new company’s identity on a landing page, RXO.com, where visitors can register to receive news about the spin-off’s upcoming milestones and leadership appointments.Brad Jacobs, chairman and chief executive officer of XPO Logistics, said, “Our spin-off now has a name — RXO — bringing it one step closer to becoming a standalone industry leader....

Continue reading

HyreCar Narrows Guidance Based on Strong Second Quarter Performance

LOS ANGELES, July 12, 2022 (GLOBE NEWSWIRE) — HyreCar Inc. (Nasdaq: HYRE), the carsharing marketplace for ridesharing and food/package delivery services, today issued revised guidance of expected net revenue between $10.4M and $10.6M, narrowing previous guidance of expected net revenue between $10.2M and $10.7M, based on the company’s strong performance in the second quarter. This would deliver a quarter over quarter revenue increase of 10% or close to $1.0M over the $9.5M revenue recorded in the first quarter of 2022, and would yield the highest quarterly net revenue in the company’s history. Demand continued to increase compared to the prior quarter despite record high gas prices. The company believes its focus on gig rentals insulated utilization and spurred driver demand amidst increasing inflation and recessionary pressure. Additionally,...

Continue reading

Rhythm Pharmaceuticals Announces Positive Interim Results from Phase 2 Clinical Trial Evaluating Setmelanotide in Hypothalamic Obesity

–All evaluable patients (N=11) achieved BMI decrease of more than 5 percent at 16 weeks on setmelanotide therapy– –17.2 percent mean reduction in BMI at 16 weeks– –15.8 percent (15.9 kg or 35.1 lb) mean weight reduction achieved at 16 weeks– –Mean change in hunger score of -2.7– –Management to host conference call at 8:00 a.m. ET today– BOSTON, July 12, 2022 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) pathway diseases, today announced positive interim results from a Phase 2 clinical trial evaluating setmelanotide, the Company’s MC4R agonist, for the treatment...

Continue reading

React Gaming’s Compete.gg granted API by Riot Games

React Gaming Group – Beyond The Press Release Click here to see interview of Ty Root, CEO of Compete.ggNew API expands Compete.gg’s competitive game offering to a whole new level with the addition of League of Legends to its esports tournament platform API also provides better gaming experience with new functionalities such as multiplayer game modes and access to full stat profiles Enhanced product offering in line with Compete.gg’s vision of offering the best gaming experience via its platform and valuable gaming insights through its main social media channels: TikTok, Discord and YouTubeClick here to see interview of Ty Root, CEO of Compete.gg MONTREAL, July 12, 2022 (GLOBE NEWSWIRE) — React Gaming Group Inc. (“React Gaming” or the “Corporation”) (TSXV: RGG, OTCMKTS: ITMZF) is pleased to announce that its esports...

Continue reading

Xos, Inc. Secures Purchase Order for 10 Stepvans from Zeem Solutions, Delivers First Vehicle to Los Angeles Depot

LOS ANGELES, July 12, 2022 (GLOBE NEWSWIRE) — Xos, Inc. (NASDAQ: XOS), a leading fleet services provider and manufacturer of Class 5 through Class 8 battery-electric vehicles, today announced it has secured a purchase order for 10 of its 100% battery-electric stepvans from Zeem Solutions (“Zeem”), a fleet-as-a-service provider that builds and operates zero-emissions fleet depots, and has delivered the first vehicle to Zeem’s Los Angeles-based depot during the second quarter of 2022. Zeem will offer Xos vehicles for lease as part of its fleet-as-a-service offering. “Zeem has created a first-of-its-kind suite of products for fleets and we’re excited to partner with them on this journey,” said Esther M. Santos, Director of North America Sales at Xos. “Xos and Zeem share a similar vision of decarbonizing transportation and supporting...

Continue reading

Sutro Biopharma Announces Virtual Deep Dive Research Forum: Next-Gen Innovations in ADCs

SOUTH SAN FRANCISCO, Calif., July 12, 2022 (GLOBE NEWSWIRE) — Sutro Biopharma, Inc. (“Sutro” or the “Company”) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that management will host a virtual research forum in which it will unveil the next product candidate, discuss immunostimulatory ADCs (iADCs) as a novel modality, and highlight recent enhancement to its cell-free manufacturing platform. Webcast details:Wednesday, July 20, 2022 at 4:30 pm ET, or 1:30 pm PT To access and register for the live webcast, please go to https://ir.sutrobio.com/news-events/ir-calendarThe webcast information will also be available through the News & Events section of the Investor Relations portion of the Company’s website at www.sutrobio.com. An archived...

Continue reading

Oncotelic Announces Presentation of P001- OT-101 Phase 1/2 Trial in Pancreatic Cancer

AGOURA HILLS, Calif., July 12, 2022 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB:OTLC), developer of treatments for rare and orphan indications, including Parkinson Disease and various cancers, today announced that the Company presentation at 7th JCA-AACR Special Joint Conference (July 8-10, 2022) is now available at https://www.oncotelic.com/wp-content/uploads/2022/07/JCA-2022.pptx.pdf and https://www.youtube.com/watch?v=D9h7ExvUUVs.Key patient inclusion criteriaNo longer amenable to established forms of therapy. At least one measurable lesion Karnofsky > 80%Key findingsOT-101 PK is dose proportional (p

Continue reading

Allied Copper Mobilizing for Drilling at the Klondike Property, Colorado in mid-July

VANCOUVER, British Columbia, Canada, July 12, 2022 (GLOBE NEWSWIRE) — Allied Copper Corp. (TSX-V: CPR, OTCQB: CPRRF) (the “Company” or “Allied Copper”), is pleased to announce that crews will be mobilizing to the Klondike property in mid-July to complete the first modern drill test of the property. Site and logistical preparation will be completed prior to the drill arriving by late July. A five hole program, costing CAD$1.25m is planned to test three target areas for a total of 1,000 metres of drilling. The Klondike Property consists of 76 unpatented mining claims, a State of Colorado Exploration Permit and an exclusive right to a State lease. “Turning the drill bit at Klondike is the major event that our shareholders, management and board have been looking forward to since the acquisition of the asset.” stated Warner Uhl, Chairman...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.